Therefore, the simultaneous inhibition of iNOS and COX-2 is crucial to achieve maximal protection as demonstrated in chemically-induced colitis [68], colitis-related carcinogenesis and CRC development in patients with IBD [69,70,71]. Here, NOS2 is linked to inflammatory bowel disease.